Bronchoprotection and bronchorelaxation in asthma: New targets, and new ways to target the old ones.
Publication/Presentation Date
8-1-2016
Abstract
Despite over 50years of inhaled beta-agonists and corticosteroids as the default management or rescue drugs for asthma, recent research suggests that new therapeutic options are likely to emerge. This belief stems from both an improved understanding of what causes and regulates airway smooth muscle (ASM) contraction, and the identification of new targets whose inhibition or activation can relax ASM. In this review we discuss the recent findings that provide new insight into ASM contractile regulation, a revolution in pharmacology that identifies new ways to "tune" G protein-coupled receptors to improve therapeutic efficacy, and the discovery of several novel targets/approaches capable of effecting bronchoprotection or bronchodilation.
Volume
164
First Page
82
Last Page
96
ISSN
1879-016X
Published In/Presented At
Pera, T., & Penn, R. B. (2016). Bronchoprotection and bronchorelaxation in asthma: New targets, and new ways to target the old ones. Pharmacology & therapeutics, 164, 82–96. https://doi.org/10.1016/j.pharmthera.2016.04.002
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
27113408
Department(s)
Administration and Leadership
Document Type
Article